Assessment of inflammatory bowel disease risk prior to commencing IL-17 inhibitors: A cross sectional analysis of Irish practice

被引：0
|
作者：
Long, Amy [1 ]
Quigley, Claire [1 ]
Murphy, Lisa [1 ]
O'Gorman, Susan [1 ]
机构：
[1] St James Hosp, Dublin, Ireland
来源：
JEADV CLINICAL PRACTICE | 2025年 / 4卷 / 01期
关键词：
D O I：
10.1002/jvc2.579
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：308 / 310
页数：3
相关论文
共 50 条
  • [21] Plasma IL-22 Levels, But Not IL-17, are Significantly Higher in Inflammatory Bowel Disease Patients Compared to the Healthy Adults
    Raza, Ali
    Ahmed, Kashif
    Navaneethan, Udayakumar
    Nady, Soad
    Shata, Mohamed
    Giannella, Ralph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S487 - S487
  • [22] Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases
    Elham Aghamohamadi
    Nastaran Asri †
    Aylin Odak
    Mohammad Rostami-Nejad
    Vahid Chaleshi
    Yasaman Hajinabi
    Maryam Eslami
    Saeed Mohammadian Haftcheshmeh
    Fahimeh Sadat Gholam-Mostafaei
    Hamid Asadzadeh-Aghdaei
    Andrea Masotti
    Mohammad Reza Zali
    Molecular Biology Reports, 2022, 49 : 6085 - 6091
  • [23] Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases
    Aghamohamadi, Elham
    Asri, Nastaran
    Odak, Aylin
    Rostami-Nejad, Mohammad
    Chaleshi, Vahid
    Hajinabi, Yasaman
    Eslami, Maryam
    Haftcheshmeh, Saeed Mohammadian
    Gholam-Mostafaei, Fahimeh Sadat
    Asadzadeh-Aghdaei, Hamid
    Masotti, Andrea
    Zali, Mohammad Reza
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (07) : 6085 - 6091
  • [24] Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study
    Busingye, Doreen
    Pollack, Allan
    Chidwick, Kendal
    PLOS ONE, 2021, 16 (05):
  • [25] Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease
    Rimola, Jordi
    Torres, Joana
    Kumar, Shankar
    Taylor, Stuart A.
    Kucharzik, Torsten
    GUT, 2022, 71 (12) : 2587 - 2597
  • [26] Knowledge, attitude, and practice of patients living with inflammatory bowel disease: A cross-sectional study
    Shao, Xiao-Xiao
    Fang, Lu-Yan
    Guo, Xu-Ri
    Wang, Wei-Zhong
    Shi, Rui-Xin
    Lin, Dao-Po
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (43) : 5818 - 5833
  • [27] Serum IL-17 and IL-23 levels can distinguish between severe and non-severe inflammatory bowel disease
    Lucaciu, L.
    Ilies, M.
    Iuga, C.
    Seicean, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S163 - S163
  • [28] Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease
    Kanai, Takanori
    Nemoto, Yasuhiro
    Kamada, Nobuhiko
    Totsuka, Teruji
    Hisamatsu, Tadakazu
    Watanabe, Mamoru
    Hibi, Toshifumi
    CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (04) : 306 - 313
  • [29] Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study
    Fonseca-Camarillo, G.
    Furuzawa-Carballeda, J.
    Granados, J.
    Yamamoto-Furusho, J. K.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 177 (01): : 64 - 75
  • [30] Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance
    Li, Qinglin
    Shan, Qiyuan
    Sang, Xianan
    Zhu, Ruyi
    Chen, Xiaocheng
    Cao, Gang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2019, 47 (01): : 177 - 201
12345